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Adult T-cell leukemia (ATL) is a neoplastic disease
caused by Human T-cell leukemia virus type 1 (HTLV-
1). ATL cells possess a CD4+CD25+ phenotype, similar
to that of regulatory T cells (Treg). The HTLV-1 bZIP
factor (HBZ), which is consistently expressed in ATL,
has a critical role in the development of ATL and
HAM/TSP. In the present study, we found that HBZ
enhanced TGF-beta/Smad transcriptional activity in a
manner dependent on p300. Co-immunoprecipitation
assay confirmed that HBZ interacted with Smad3, and
formed a ternary complex with Smad3 and p300. In the
presence of HBZ, the interaction between Smad3 and
p300 was enhanced. The N-terminal LXXLL motif of
HBZ was essential for HBZ-mediated TGF-beta signal-
ing activation, while Smad3 interacted with HBZ
through its C-terminal MH2 domain. Furthermore,
physiological level of HBZ could rescue the repressed
TGF-beta responses by Tax. We also found that HBZ acti-
vated transcription of the Foxp3 gene through its Smad
site. Our study shows that HBZ enhances TGF-beta sig-
naling while Tax suppresses this pathway, and this enhan-
cing activity leads to transcription of Foxp3 gene.
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